Expert Recommendations for Optimizing Outcomes in the Management Of Biofilm to Promote Healing of Chronic Wounds in the Veterans Health Administration System

A supplement to Federal Practitioner. This supplement is sponsored by Organogenesis, Inc.

Chronic non-healing wounds are a major problem for patients and wound care practitioners in the VA system. It is self-evident among experienced wound care practitioners that wound infection can delay (or completely prevent) wound healing. Biofilm is a common form of wound contamination that is now recognized to be a major factor in delaying the healing of wounds.

 

This supplement discusses the awareness of the biology of biofilm, its prevalence, its clinical significance, and optimal treatment approaches that need to be improved. The supplement also reviews the current status of evidence-based management of biofilm with a focus on the optimal use of PuraPly™ Antimicrobial, a native purified collagen matrix containing the antimicrobial polyhexamethylene biguanide (PHMB).

A supplement to Federal Practitioner. This supplement is sponsored by Organogenesis, Inc.

Chronic non-healing wounds are a major problem for patients and wound care practitioners in the VA system. It is self-evident among experienced wound care practitioners that wound infection can delay (or completely prevent) wound healing. Biofilm is a common form of wound contamination that is now recognized to be a major factor in delaying the healing of wounds.

 

This supplement discusses the awareness of the biology of biofilm, its prevalence, its clinical significance, and optimal treatment approaches that need to be improved. The supplement also reviews the current status of evidence-based management of biofilm with a focus on the optimal use of PuraPly™ Antimicrobial, a native purified collagen matrix containing the antimicrobial polyhexamethylene biguanide (PHMB).

A supplement to Federal Practitioner. This supplement is sponsored by Organogenesis, Inc.

Chronic non-healing wounds are a major problem for patients and wound care practitioners in the VA system. It is self-evident among experienced wound care practitioners that wound infection can delay (or completely prevent) wound healing. Biofilm is a common form of wound contamination that is now recognized to be a major factor in delaying the healing of wounds.

 

This supplement discusses the awareness of the biology of biofilm, its prevalence, its clinical significance, and optimal treatment approaches that need to be improved. The supplement also reviews the current status of evidence-based management of biofilm with a focus on the optimal use of PuraPly™ Antimicrobial, a native purified collagen matrix containing the antimicrobial polyhexamethylene biguanide (PHMB).